☰

Ernst Rudolf Berndt

Affiliations: 
1973-1980 University of British Columbia, Vancouver, Vancouver, BC, Canada 
 1980- Massachusetts Institute of Technology, Cambridge, MA, United States 
Website:
https://mitsloan.mit.edu/faculty/directory/ernst-rudolf-berndt
Google:
"Ernst Berndt"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Laurits R. Christensen grad student 1968-1972 UW Madison

Children

Sign in to add trainee
Erik Brynjolfsson grad student
Arthur Lewbel grad student

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stern AD, Chen JL, Ouellet M, et al. (2021) Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users. Health Affairs (Project Hope). 40: 989-999
Conti RM, Berndt ER. (2020) FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS. International Journal of the Economics of Business. 27: 27-48
Frank RG, Hicks A, Berndt ER. (2020) The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines. Medical Care Research and Review : McRr. 1077558720921100
Kaygisiz NB, Shivdasani Y, Conti RM, et al. (2019) The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications National Bureau of Economic Research
Adajar PM, Berndt ER, Conti RM. (2019) The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration National Bureau of Economic Research
Berndt ER, Conti RM, Murphy SJ. (2018) The generic drug user fee amendments: an economic perspective. Journal of Law and the Biosciences. 5: 103-141
Bosworth B, Bieler J, Kleinrock M, et al. (2018) An Evaluation of the CPI Indexes for Prescription Drugs National Bureau of Economic Research
Berndt ER, Conti RM, Murphy SJ. (2017) The Landscape of US Generic Prescription Drug Markets, 2004-2016 National Bureau of Economic Research
Aitken M, Berndt ER, Cutler D, et al. (2016) Has The Era Of Slow Growth For Prescription Drug Spending Ended? Health Affairs (Project Hope). 35: 1595-603
Berndt ER, Dubois P. (2016) Impacts of Patent Expiry on Daily Cost of Pharmaceutical Treatments in Eight OECD Countries, 2004–2010 International Journal of the Economics of Business. 23: 125-147
See more...